Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial

Title
Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
Authors
Keywords
COVID-19, baloxavir marboxil, favipiravir, pharmacokinetics, the half-maximal effective concentration (EC, 50, )
Journal
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume -, Issue -, Pages 105631
Publisher
Elsevier BV
Online
2020-10-25
DOI
10.1016/j.ejps.2020.105631

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started